Financial Management Professionals’s United Therapeutics UTHR Stock Holding History

Financial Management Professionals’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.17K	Hold	4	–	–	﹤0.01%	785
2026 Q1	$2.37K	Hold	4	–	–	﹤0.01%	706
2025 Q4	$1.95K	Hold	4	–	–	﹤0.01%	732
2025 Q3	$1.68K	Hold	4	–	–	﹤0.01%	730
2025 Q2	$1.15K	Hold	4	–	–	﹤0.01%	817
2025 Q1	$1.23K	Hold	4	–	–	﹤0.01%	789
2024 Q4	$1.41K	Hold	4	–	–	﹤0.01%	772
2024 Q3	$1K	Hold	4	–	–	﹤0.01%	898
2024 Q2	$1K	Hold	4	–	–	﹤0.01%	865
2024 Q1	$1K	Hold	4	–	–	﹤0.01%	915
2023 Q4	$1K	Hold	4	–	–	﹤0.01%	902
2023 Q3	$1K	Hold	4	–	–	﹤0.01%	845
2023 Q2	$1K	Hold	4	–	–	﹤0.01%	884
2023 Q1	$1K	Hold	4	–	–	﹤0.01%	957
2022 Q4	$1K	Hold	4	–	–	﹤0.01%	878
2022 Q3	$1K	Hold	4	–	–	﹤0.01%	877
2022 Q2	$1K	Hold	4	–	–	﹤0.01%	898
2022 Q1	$1K	Hold	4	–	–	﹤0.01%	975
2021 Q4	$1K	Hold	4	–	–	﹤0.01%	914
2021 Q3	$1K	Hold	4	–	–	﹤0.01%	900
2021 Q2	$1K	Buy	+4	New	+$762	﹤0.01%	851

Other funds holding UTHR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Norges Bank Oslo, Norway $1T AUM

Financial Management Professionals's UTHR Position: Q2 2026 in Review

Financial Management Professionals held its United Therapeutics (UTHR) position steady in Q2 2026 at 4 shares worth $2.17K. The position accounts for ﹤0.01% of the portfolio, ranked #785.

Financial Management Professionals first reported a position in UTHR in Q2 2021 and has held it in 21 quarters since. The position peaked at $2.37K in Q1 2026. 875 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

Financial Management Professionals held 4 shares of United Therapeutics worth $2.17K as of Q2 2026.
Financial Management Professionals left its United Therapeutics share count unchanged in Q2 2026.
United Therapeutics made up ﹤0.01% of Financial Management Professionals's portfolio in Q2 2026, its #785 holding.
Financial Management Professionals first reported a position in United Therapeutics in Q2 2021 and has held it in 21 quarters since.
Financial Management Professionals's United Therapeutics position peaked at $2.37K in Q1 2026.
875 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Financial Management Professionals's 13F filing for Q2 2026, filed 9 Jul 2026.